Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Jump to content
Independent

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Independent Bulletin homepage

Social Partner

We are 8 logo (opens in a new tab)We are 8 logoWe are 8 logo
  1. All
  2. News
  3. Sport
  4. Culture
  5. Lifestyle

The ‘revolutionary’ blood test offering new hope to lung and breast cancer patients

By identifying specific genetic mutations, the liquid biopsy eliminates the need for traditional tissue biopsies in many cases
By identifying specific genetic mutations, the liquid biopsy eliminates the need for traditional tissue biopsies in many cases (Getty/iStock)
  • NHS England is introducing a liquid biopsy blood test to analyse tumour DNA, enabling personalised treatments for lung and breast cancer patients.
  • The blood test eliminates the need for traditional tissue biopsies in many cases, reducing wait times and enabling quicker access to targeted therapies; 15,000 patients are expected to benefit each year.
  • Lung cancer is the most common cause of cancer death in the UK, with smoking being the main cause, but it can also have genetic causes and links to pollution, obesity, asbestos exposure and certain work-based chemicals.
  • A persistent cough, recurring chest infections, shortness of breath, and blood in phlegm are key symptoms of lung cancer, according to experts.
  • Other potential signs of lung cancer include unexplained weight loss, fatigue, loss of appetite, shoulder or chest pain, and a hoarse voice.
In full

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in